Cryoport
Lake Forest
About Cryoport
Cryoport delivers an innovative and complete outsourced frozen shipping solution for biological materials. This breakthrough combination replaces outdated dry ice shipping, virtually eliminates the risk of cell degradation and revolutionizes deep frozen logistics. We combine the technology of liquid nitrogen dry vapor shippers with the most advanced Logistics Management Platform in the industry. When added with our logistics expertise, we provide a complete outsourced solution that advances deep-frozen shipping for the life science community. Whether your business is bio-pharmaceuticals, clinical trials, research or reproductive medicine, you want to focus on your core mission. Cryoport will help you transport life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $1.1B
- Funding stage: IPO
- Last round: Post-IPO Debt (Nov 2021)
- Ticker: nasdaq:CYRX
- Website: cryoport.com
- Phone: (949)232-1900
Industries & Categories
Clinical Trials, Logistics, Shipping
Social Profiles
Canonical: https://fsome.com/organization/cryoport-134627 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.